Resultados de la búsqueda 731-740 of 17287 for treatment resistant depression
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a ...
A Registry for Children Treated with Proton Radiation Therapy ... Also want to find out if kidney tumor treatment leads to an improvement in these immune markers.
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And ...
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma. Rochester, Minn. The purpose of this study is to ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study to ...
Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. ... Journal of Substance Abuse Treatment. 2017;81:53 ...
... therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the ...
... resistance to immune checkpoint modulating agents that lead to the identification of sensitivity/resistance ... Treatment (Temozolomide) for Brain Tumors That ...
Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. ... The purpose of phase 2a is to establish proof-of ... treatment. This ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?